脓毒症分子内型的预后评估:巴西多中心队列研究
这项前瞻性、多中心、观察性研究在巴西4个ICU纳入168例首次诊断脓毒症(Sepsis 3标准)的成人患者和25名医护人员对照,用qRT-PCR定量8个基因转录水平以判定Mars1–Mars4四种分子内型。总死亡率44%,Mars1组28天死亡率高于非Mars1组,log-rank检验显示Mars1亚组生存概率最差(P=0.013),风险比1.78(P=0.017)。与对照相比,诊断脓毒症的ROC曲线AUC为Mars1 0.69、Mars2 0.89、Mars3 0.82、Mars4 0.71。作者认为,在低至中等收入国家,qRT-PCR检出的Mars1内型与更差的脓毒症生存相关,Mars2内型可能是脓毒症的诊断标志物。
要点
- 在巴西4个ICU的168例脓毒症患者中,Mars1内型28天死亡率高于非Mars1组,log-rank检验P=0.013,风险比1.78(P=0.017)。
- 总死亡率44%,Mars1亚组生存概率最差,提示该内型可用于识别高危脓毒症患者。
- 与对照相比,Mars2诊断脓毒症的AUC为0.89(SD 0.85-0.94,P<0.0001),作者认为其可能是脓毒症的诊断标志物。
- Mars1诊断脓毒症的AUC为0.69(SD 0.62-0.77,P=0.0016),Mars4为0.71(SD 0.64-0.79,P<0.0006)。
- 内型判定采用qRT-PCR定量8个基因转录水平,纳入标准为首次24小时内依据Sepsis 3标准诊断脓毒症的成人。
适用人群与场景
- 巴西4个ICU的成人患者,纳入标准为首次24小时内依据Sepsis 3标准诊断脓毒症。
- 对照组为医护人员。
诊断标准与关键阈值
- 脓毒症诊断依据Sepsis 3标准。
- 分子内型Mars1、Mars2、Mars3、Mars4通过qRT-PCR定量8个基因转录水平判定。
研究设计与关键结果
- 研究类型为前瞻性、多中心、观察性研究,纳入168例脓毒症患者和25名对照,来自巴西4个ICU。
- 总死亡率44%。
- Mars1组28天死亡率高于非Mars1组,log-rank检验显示Mars1亚组生存概率最差(P=0.013),风险比1.78(P=0.017)。
- 与对照相比,诊断脓毒症的ROC曲线AUC:Mars1 0.69(SD 0.62-0.77,P=0.0016)、Mars2 0.89(SD 0.85-0.94,P<0.0001)、Mars3 0.82(SD 0.75-0.88,P<0.0001)、Mars4 0.71(SD 0.64-0.79,P<0.0006)。
证据类型、等级与局限
- 证据类型:前瞻性、多中心、观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,qRT-PCR检出的Mars1内型与低至中等收入国家脓毒症患者更差的生存相关。
- 作者认为,Mars2内型可能是脓毒症的诊断标志物。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sepsis heterogeneity affects the identification of high-risk patients. Outcomes in low- and middle-income countries are worse than those in developed nations. This study aimed to assess the prognostic potential of the previously described molecular endotypes, Mars1, Mars2, Mars3, and Mars4, in a Brazilian cohort with sepsis.
MATERIAL AND METHODS: This prospective, multicenter, observational study identified molecular expression-based endotypes in adults from four intensive care units in Brazil. Patients on their first 24-h diagnosis of sepsis based on the Sepsis 3 criteria were included. Health care workers were included in the control group. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to quantify the transcripted levels of eight genes and determine the four endotypes. The primary endpoint was 28-day mortality with a secondary analysis of diagnostic accuracy. Statistical significance was set at P < 0.05.
RESULTS: One hundred sixty-eight participants and twenty-five controls were enrolled in this study. The overall mortality rate was 44%. The Mars1 group showed a higher 28-day mortality than the non-Mars1 group. The log-rank test showed a worst survival probability in Mars1 subgroup ( P = 0.013), and the hazard ratio was 1.78 ( P = 0.017). Compared to control, area-under-the-curve (AUC) of ROC curves for diagnosing sepsis were: 0.69 for Mars1 (SD 0.62-0.77 / P = 0.0016), 0.89 for Mars2 (SD 0.85-0.94 / P < 0.0001), 0.82 for Mars3 (SD 0.75-0.88 / P < 0.0001), and 0.71 for Mars4 (SD 0.64-0.79 / P < 0.0006).
CONCLUSION: The Mars1 endotype detected by qRT-PCR was associated with worse sepsis survival in low-to middle-income countries. We also identified the Mars 2 endotype as a potential diagnostic marker for sepsis.
参考来源
- De Stefani FDC, de Miranda AC, Dal Vesco BC, et al. Prognostic Evaluation of Molecular Endotypes in Sepsis: A Multicenter Cohort Study in Brazil. Shock. 2025. PMID: 40705347. doi:10.1097/SHK.0000000000002661
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。